Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro

Toxicology

Volumn 292, Issue 1, 2012, Pages 53-62

  Xiao, Jing ^a   Sun, Gui Bo ^a   Sun, Bing ^a   Wu, Ying ^a   He, Ling ^a   Wang, Xin ^a   Chen, Rong Chang ^a   Cao, Li ^a   Ren, Xiao Yu ^a   Sun, Xiao Bo ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

Apoptosis; Doxorubicin; Flavonoid; Heart; Kaempferol

Indexed keywords

CASPASE 3; DOXORUBICIN; FAS ANTIGEN; JANUS KINASE; KAEMPFEROL; LACTATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY GROWTH; CARDIOTOXICITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; HEART DEVELOPMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION;

ANIMALS; CARDIOTONIC AGENTS; CARDIOTOXINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; KAEMPFEROLS; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84855317775     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.11.018     Document Type: Article

References (52)

1. Areias F.M., Rego A.C., Oliveira C.R., Seabra R.M. Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells. Biochem. Pharmacol. 2001, 62:111-118.
2. Arola O.J., Saraste A., Pulkki K., Kallajoki M., Parvinen M., Voipio-Pulkki L.M. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000, 60:1789-1792.
3. Basu A., Haldar S. The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol. Hum. Reprod. 1998, 4:1099-1109.
4. Bennink R.J., van den Hoff M.J., van Hemert F.J., de Bruin K.M., Spijkerboer A.L., Vanderheyden J.L., Steinmetz N., van Eck-Smit B.L. Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats. J. Nucl. Med. 2004, 45:842-848.
5. Bhathena S.J., Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr. 2002, 76:1191-1201.
6. Bhouri W., Bouhlel I., Boubaker J., Kilani S., Ghedira K., Ghedira L.C. Induction of apoptosis in human lymphoblastoid cells by kaempferol 3-O-beta-isorhamninoside and rhamnocitrin 3-O-beta-isorhamninoside from Rhamnus alaternus L. (Rhamnaceae). Cell Prolif. 2011, 44:283-290.
7. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., Yancopoulos G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991, 65:663-675.
8. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
9. Fisher P.W., Salloum F., Das A., Hyder H., Kukreja R.C. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 2005, 111:1601-1610.
10. Giri S.N., Al-Bayati M.A., Du X., Schelegle E., Mohr F.C., Margolin S.B. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats. Cancer Chemother. Pharmacol. 2004, 53:141-150.
11. Hamilton A., Larsimont D., Paridaens R., Drijkoningen M., van de Vijver M., Bruning P., Hanby A., Houston S., Treilleux I., Guastalla J.P., Van Vreckem A., Sylvester R., Piccart M. A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923. Clin. Breast Cancer 2000, 1:233-240. (discussion 241-242).
12. Han J.M., Jin Y.Y., Kim H.Y., Park K.H., Lee W.S., Jeong T.S. Lavandulyl flavonoids from Sophora flavescens suppress lipopolysaccharide-induced activation of nuclear factor-kappaB and mitogen-activated protein kinases in RAW264.7 cells. Biol. Pharm. Bull. 2010, 33:1019-1023.
13. Hendriks J.J., de Vries H.E., van der Pol S.M., van den Berg T.K., van Tol E.A., Dijkstra C.D. Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem. Pharmacol. 2003, 65:877-885.
14. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342:1007-1011.
15. Hollman P.C., Katan M.B. Health effects and bioavailability of dietary flavonols. Free Radic. Res. 1999, 31(Suppl.):S75-S80.
16. Huang C.H., Jan R.L., Kuo C.H., Chu Y.T., Wang W.L., Lee M.S., Chen H.N., Hung C.H. Natural flavone kaempferol suppresses chemokines expression in human monocyte THP-1 cells through MAPK pathways. J. Food Sci. 2010, 75:H254-H259.
17. Huang J., Yang J., Maity B., Mayuzumi D., Fisher R.A. Regulator of G protein signaling 6 (RGS6) mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species (ROS)-dependent mechanism. Cancer Res. 2011, 337:747-754.
18. Ishikawa Y., Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int. 2000, 58:1078-1087.
19. Jahnukainen K., Jahnukainen T., Salmi T.T., Svechnikov K., Eksborg S., Soder O. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats. Cancer Res. 2001, 61:6423-6427.
20. Jang Y.J., Kim J., Shim J., Byun S., Oak M.H., Lee K.W., Lee H.J. Kaempferol attenuates 4-hydroxynonenal-induced apoptosis in PC12 cells by directly inhibiting NADPH oxidase. J. Pharmacol. Exp. Ther. 2011, 337:747-754.
21. Jin C.Y., Park C., Kim G.Y., Lee S.J., Kim W.J., Choi Y.H. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chem. Biol. Interact. 2009, 180:143-150.
22. Kalay N., Basar E., Ozdogru I., Er O., Cetinkaya Y., Dogan A., Inanc T., Oguzhan A., Eryol N.K., Topsakal R., Ergin A. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J. Am. Coll. Cardiol. 2006, 48:2258-2262.
23. Kawamura T., Hasegawa K., Morimoto T., Iwai-Kanai E., Miyamoto S., Kawase Y., Ono K., Wada H., Akao M., Kita T. Expression of p300 protects cardiac myocytes from apoptosis in vivo. Biochem. Biophys. Res. Commun. 2004, 315:733-738.
24. Keyhanian S., Stahl-Biskup E. Phenolic constituents in dried flowers of aloe vera (Aloe barbadensis) and their in vitro antioxidative capacity. Planta Med. 2007, 73:599-602.
25. Kim J.M., Lee E.K., Kim D.H., Yu B.P., Chung H.Y. Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase. Age (Dordr.) 2010, 32:197-208.
26. Kotamraju S., Konorev E.A., Joseph J., Kalyanaraman B. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J. Biol. Chem. 2000, 275:33585-33592.
27. Kovacic P., Somanathan R. Cell signaling and receptors with resorcinols and flavonoids: redox, reactive oxygen species, and physiological effects. J. Recept. Signal Transduct. Res. 2011, 31:265-270.
28. Lai H.C., Liu T.J., Ting C.T., Sharma P.M., Wang P.H. Insulin-like growth factor-1 prevents loss of electrochemical gradient in cardiac muscle mitochondria via activation of PI 3 kinase/Akt pathway. Mol. Cell. Endocrinol. 2003, 205:99-106.
29. Lee E.J., Ji G.E., Sung M.K. Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells. Inflamm. Res. 2010, 59:847-854.
30. Lee E.R., Kang Y.J., Kim J.H., Lee H.T., Cho S.G. Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J. Biol. Chem. 2005, 280:31498-31507.
31. Li N., Liu J.H., Zhang J., Yu B.Y. Comparative evaluation of cytotoxicity and antioxidative activity of 20 flavonoids. J. Agric. Food Chem. 2008, 56:3876-3883.
32. Lin J., Rexrode K.M., Hu F., Albert C.M., Chae C.U., Rimm E.B., Stampfer M.J., Manson J.E. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am. J. Epidemiol. 2007, 165:1305-1313.
33. Liu J., Mao W., Ding B., Liang C.S. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am. J. Physiol.: Heart Circ. Physiol. 2008, 295:H1956-H1965.
34. Liu T.J., Yeh Y.C., Ting C.T., Lee W.L., Wang L.C., Lee H.W., Wang K.Y., Lai H.C. Ginkgo biloba extract 761 reduces doxorubicin-induced apoptotic damage in rat hearts and neonatal cardiomyocytes. Cardiovasc. Res. 2008, 80:227-235.
35. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K., Young R.C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 1977, 197:165-167.
36. Notas G., Nifli A.P., Kampa M., Pelekanou V., Alexaki V.I., Theodoropoulos P., Vercauteren J., Castanas E. Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells. J. Nutr. Biochem. 2011, 10.1016/j.jnutbio.2011.03.010.
37. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
38. Olszewska M. Separation of quercetin, sexangularetin, kaempferol and isorhamnetin for simultaneous HPLC determination of flavonoid aglycones in inflorescences, leaves and fruits of three Sorbus species. J. Pharm. Biomed. Anal. 2008, 48:629-635.
39. Park M.J., Lee E.K., Heo H.S., Kim M.S., Sung B., Kim M.K., Lee J., Kim N.D., Anton S., Choi J.S., Yu B.P., Chung H.Y. The anti-inflammatory effect of kaempferol in aged kidney tissues: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinase pathways. J. Med. Food 2009, 12:351-358.
40. Prochazkova J., Lichnovsky V., Kylarova D., Erdosova B., Vranka P. Involvement of p53 and Bcl-2 family proteins in regulating programmed cell death and proliferation in human embryogenesis. Gen. Physiol. Biophys. 2004, 23:209-229.
41. Regula K.M., Kirshenbaum L.A. Apoptosis of ventricular myocytes: a means to an end. J. Mol. Cell. Cardiol. 2005, 38:3-13.
42. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9:402-412.
43. Su B., Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 1996, 8:402-411.
44. Tran S.E., Holmstrom T.H., Ahonen M., Kahari V.M., Eriksson J.E. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 2001, 276:16484-16490.
45. Usui T. Pharmaceutical prospects of phytoestrogens. Endocr. J. 2006, 53:7-20.
46. Wallace K.B. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol. Toxicol. 2003, 93:105-115.
47. Xiao J., Sun B., Cai G.P. Transient expression of interferon-inducible p204 in the early stage is required for adipogenesis in 3T3-L1 cells. Endocrinology 2010, 151:3141-3153.
48. Yao L.H., Jiang Y.M., Shi J., Tomas-Barberan F.A., Datta N., Singanusong R., Chen S.S. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 2004, 59:113-122.
49. Yeh E.T., Tong A.T., Lenihan D.J., Yusuf S.W., Swafford J., Champion C., Durand J.B., Gibbs H., Zafarmand A.A., Ewer M.S. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004, 109:3122-3131.
50. Yeh Y.C., Lai H.C., Ting C.T., Lee W.L., Wang L.C., Wang K.Y., Liu T.J. Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem. Pharmacol. 2007, 74:969-980.
51. Yoshida M., Shiojima I., Ikeda H., Komuro I. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J. Mol. Cell. Cardiol. 2009, 47:698-705.
52. Zhang Y.W., Shi J., Li Y.J., Wei L. Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch. Immunol. Ther. Exp. (Warsz.) 2009, 57:435-445.